Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-26

Clinical Trial Update: Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial update comparing BRV to LEV in epilepsy focusing on pharmacodynamic efficacy and onset time in photosensitive epilepsy, with the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BRIVARACETAM (brivaracetam)
  • LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Rosenfeld, William E., M.D. | Conditions: Photosensitive Epilepsy | Phase 2, Phase 3 | Status: COMPLETED